• 한국수산과학회지
• /
• 제42권3호
• /
• pp.257-261
• /
• 2009

Two feeding trials were conducted to investigate the effects of several dietary additives on growth and feed utilization of juvenile flounder. In the first experiment, three replicate groups of juveniles (average weight 1.5 g) were fed diets with or without wasabi extract and chitosan for 7 weeks. Survival rate, weight gain, protein efficiency ratio, hepatosomatic index and condition factor were not affected by the different dietary additives (P>0.05). Feed efficiency of fish fed the wasabi extract diet was significantly higher than that of fish fed the control diet (P<0.05). Daily feed intake of fish fed the wasabi extract diet was significantly lower than that of fish fed the other diets (P<0.05). In the second experiment, three replicate groups of juveniles (average weight 1.4 g) were fed diets with or without Pophyra powder for 7 weeks. Survival rate and weight gain were not significantly affected by dietary Pophyra powder (P>0.05). Feed efficiency and protein efficiency ratio of fish fed the Pophyra diet were significantly lower than those of fish fed the control diet (P<0.05). The results of these experiments suggest that feed efficiency of juvenile flounder may be improved by dietary supplementation with wasabi extract.

• 한국축산식품학회지
• /
• 제20권1호
• /
• pp.15-20
• /
• 2000

The effects of dietary chitosan on lipid oxidation, fatty acid composition and blood profile of porks were investigated. A total 24 pigs(55$\pm$5kg) were fed a control diet (a commercial diet) or chitosan-supplemented diets (T1; 0.2% chitosan, T2; 0.4% chitosan, T3; 0.6% chitosan) for 6 weeks. After six weeks, pigs were slaughtered and bellies were collected from each treatment group. Samples were stored at 0$\pm$1$^{\circ}C$ for 14 days. The thiobarbituric acid reaction substance(TBARS) values of all the treatments increased until 7 days of storage. The fatty acid and crude fat composition of all the treatments were not changed during storage significantly. The total cholesterol and triglyceride in blood chemistry tend to lower chitosan supplemented groups then control group.

• 한국유기농업학회지
• /
• 제22권3호
• /
• pp.483-490
• /
• 2014

본 연구는 키토산올리고당의 음수 내 급여가 따른 육계의 혈액성상, 면역력 및 항산화효소계에 미치는 영향을 알아보기 위해 1일령 Arbor Acre종 약 2만 8천수를 대조구와 키토산 음수 급여구로 나누어 5주 동안 실시하였다. 육계의 혈액 성상에서 Glucose의 농도는 대조구보다 키토산올리고당 음수 급여구가 유의적으로 감소하였으나, Triglyceride, Total cholesterol, HDL-cholesterol 및 LDL-cholesterol 농도에는 대조구와 키토산올리고당 음수 급여구간에 차이를 보이지 않았고 간 손상에 대한 인자인 GOT농도는 시험구간에 차이가 없었지만 GPT농도는 대조구보다 키토산올리고당 음수 급여구가 유의적으로 감소하였다(P<0.05). 혈액 내 면역글로블린 농도 중, IgG 농도는 대조구와 키토산올리고당 음수 급여구간에 차이가 없었으나, IgM 농도는 대조구보다 키토산올리고당 음수 급여구가 유의적으로 증가하였다(P<0.05). 항산화력과 SOD의 농도는 시험구간에 차이가 없었으며, Catalase와 Glutathione peroxidase의 농도는 대조구보다 키토산올리고당 음수 급여구가 유의적으로 증가하였다(P<0.05). 따라서, 키토올리고당의 음수 급여로 인해 육계의 당대사, 면역기능 및 1차 항산화 효소계의 활성을 증가시켜 육계의 강건성에 영향을 미칠 수 있음을 보여주었다.

• 생명과학회지
• /
• 제14권3호
• /
• pp.385-390
• /
• 2004

키토산은 자연에 풍부하게 존재하는 다당의 중합체로 식품이나 약제의 성분으로 활용성이 있어 많은 연구가 이루어져 왔다. 본 연구에서는 키토산 투여와 저칼슘사료 급이가 랫드에서 골절의 치유과정에 미치는 영향을 실험하였다. 좌측 대퇴골을 골절시킨 후 핀을 골내에 삽입하여 고정하였다. 이후 랫드에 일반사료 또는 저칼슘사료를 급이하고 키토산을 0, 50, 100, 150 mg/kg 용량으로 10주간 주 5회 경구투여 하였다. 실험종료 시에 골절시킨 대퇴골의 X-ray 촬영과 물리적 측정을 실시하였다. X-ray필름 관찰에서는 골절을 유발한 모든 대퇴골에서 골절치유의 과정과 가골이 형성되었다. 물리적인 골강도 측정에서는 저칼슘사료를 급이한 랫드에서 일반사료를 급이한 랫드에 비해 최대하중과 강도의 감소를 나타내었다. 키토산을 투여한 랫드와 부형제를 투여한 랫드에서의 대퇴골의 최대하중과 강도의 차이는 없었다 또한 키토산 투여 및 저칼슘사료 급이는 최대하중과 강도에 대한 골절유발 대퇴골/비유발 대퇴골의 비율에는 영향을 미치지 않았다. 이 같은 결과로 보아 키토산은 골절의 치유과정과 제의 물리적 강도에 영향을 미치지 않는 것으로 사료된다. 또한 저칼슘사료 급이는 뼈의 물리적 강도를 감소시키는 것으로 사료된다.

• 한국지역사회생활과학회지
• /
• 제19권1호
• /
• pp.75-85
• /
• 2008

This study investigated the effects of chitosan on mineral metabolism in rats exposed to cadmium by oral administration. Six week-old Sprague-Dawley rats were divided into eight groups. Four groups were fed AIN-93G based 3% ${\alpha}$-cellulose diets and the other four groups were fed 3% chitosan diets for four weeks with the oral administration of 0, 0.5, 1.0, 2.0 mg Cd/2ml distilled water three times per week, respectively. The essential mineral contents of serum, liver, kidney and bone (femur and lumbar), and the excretion of calcium in feces and urine were determined. There was no significant difference in weight gain and food intake among groups. The cadmium administration significantly decreased calcium in serum, iron in blood, calcium and iron in liver and iron contents in kidney. In contrast, calcium and zinc contents in kidney increased by the administration of cadmium. The weight, length and breaking forces of the femur and lumbar were not significantly different due to cadmium administration and chitosan among the groups. The fecal excretion of calcium was increased by the administration of cadmium. On the other hand, calcium absorption and the absorption rate were decreased by Cd administration. In the groups without Cd administered (N, N-Chi groups), chitosan significantly decreased the absorption rate of calcium by increasing the excretion in feces (p<0.05). These results suggest that cadmium administration may facilitate the decline of essential minerals in rats and also, chitosan may have a conflicting effect between cadmium and the essential minerals of tissues.

• 한국식품영양과학회지
• /
• 제34권3호
• /
• pp.336-341
• /
• 2005

본 연구에서는 납을 경구투여 (20㎎/day)하고 3% 또는 5% 키토산 식이를 8주간 섭취하였을 때 혈액과 조직 (간, 신장 대퇴골)에서의 납 함량과 무기질 (철, 아연, 칼슘) 함량을 조사하였다 첫째 실험동물의 체중증가량, 식이섭취량과 식이 효율은 모든 실험 군간에 유의적 인 차이를 보이지 않았다. 둘째 혈액의 납 농도는 키토산을 섭취한 군이 섭취하지 않은 군에 비해서 감소하였다(p＆lt;0.01). 혈액의 철과 아연은 Pb-C5군(납 20m/day 투여 ,5% 키토산 식이군)에서 정상 대조군(N군)에 비해 감소하였으나 3%키토산 식이군에서는 유의적인 차이를 보이지 않았다(p＆lt;0.05). 혈액의 칼슘농도는 납을 투여 한 군이 납을 투여하지 않은 군에 비해서 감소하였다(p＆lt;0.05). 셋째간의 납 농도는 키토산 섭취 수준에 따른 영향이 없었다. 간의 아연과 칼슘 농도는 Pb-C5군(납 20 m/day 투여, 5% 키토산 식이군)에서 정상 대조군(N군)에 비해 감소하였으나 3% 키토산 식이군에서는 유의적인 차이를 보이지 않았다(p＆lt;0.05).넷째 신장의 아연 농도는Pb-C5군(납 20㎎/day 투여, 5% 키토산 식이군)에서 가장 낮았으나 철과 칼슘은 군간에 유의적인 차이를 보이지 않았다. 다섯째 대퇴골의 납 함량은 키토산을 섭취한 군이 섭취하지 않은 군에 비해서 감소하였으며 대퇴골의 파단력은 정상 대조군(N군)에 비해서 납 투여군에서 감소하였다 대퇴골의 칼슘은 납 투여에 의해서 감소하였으나 키토산 섭취 수준에 따라서는 영향을 받지 않았다. 결론적으로 본 연구에서는 납 투여에 의해서 증가된 혈액과 조직(간, 신장, 대퇴골)의 납 함량이 키토산 섭취에 따라서 감소하는 경향을 보였으며 특히 혈액은 유의적인 감소효과를 나타내어 키토산이 중금속의 흡수를 방해함을 알 수 있었다. 또한 납 투여에 따라 무기질의 수준도 다소 감소하는 경향을 보였는데 키토산에 의해서도 역시 감소하는 경향을 나타냈다. 특히 5%키토산 식 이 군에서 는 정 상 대조군(N군)보다 유의적인 감소를 나타냈으나 3% 키토산 식이군에서는 유의적인 차이를 보이지 않은 것으로 볼 때 키토산의 수준에 따라 무기질에 미치는 영향이 다르게 평가되었다 그러므로 키토산의 섭취 시 적절한 키토산의 수준과 무기질의 영양상태를 충분히 고려해야 할 것으로 사료된다.

• Nutrition Research and Practice
• /
• 제1권3호
• /
• pp.175-179
• /
• 2007

The present study was performed to elucidate the hypocholesterolemic action of chitosan on the diet-induced hypercholesterolemia in rats. Male Sprague-Dawley rats (n=24) were fed with chitosan-free diet (Control), diets containing 2% or 5% chitosan for 4 weeks. Hypercholesterolemia was induced by adding 1% cholesterol and 0.5% cholic acid to all diets. Body weight gain and food intake of rats did not differ among the groups. The chitosan treated groups showed significant improvement in the plasma concentration of total cholesterol and LDL-cholesterol compared to the control group (p<0.05). Also, the chitosan treated groups decreased the liver concentration of total lipid and total cholesterol compared to the control group (p<0.05). The activity of hepatic cholesterol $7{\alpha}-hydroxylase$ (CYP7A1), the rate-limiting enzyme in the conversion of cholesterol to bile acids, was increased by 123% and 165% for the 2% or 5% chitosan diets, respectively. These findings suggest that enhancement of hepatic CYP7A1 activity may be a mechanism, which can partially account for the hypocholesterolemic effect of dietary chitosan in cholesterol metabolism.

• 한국지역사회생활과학회지
• /
• 제18권4호
• /
• pp.569-578
• /
• 2007

This study investigated the effects of chitosan on cadmium(Cd) toxicity and mineral metabolism in rats exposed to cadmium by oral administration. Six week-old Sprague-Dawley rats were divided into eight groups. Four groups were fed AIN-93G based 3% ${\alpha}$-cellulose diets while the others were fed 3% chitosan diets for four weeks with oral administration of 0, 0.5, 1.0, 2.0 mg Cd/2ml distilled water three times a week, respectively. Cd contents in the serum, liver, kidney, testis and bone, and the excretion of cadmium in feces were determined. There was no significant difference in weight gain and food intake among groups. Cadmium contents in the serum, liver, kidney, testis, femur and lumbar were significantly increased in proportion to the administration level of Cd (p<0.05). A protective effect of chitosan on cadmium toxicity in tissue was shown only in the high level cadmium-intake group. The fecal excretion, absorption of Cd were increased by the administration levels of cadmium. These results suggest that Cd administration may facilitate the accumulation of Cd in the blood and tissue in proportion to the amount of administration, and also, that chitosan may be effective in lowering the accumulation of cadmium.

• 한국임상수의학회지
• /
• 제23권3호
• /
• pp.251-257
• /
• 2006

This study was performed to investigate the growth rate, hematological and serological changes of the rats when they were fed with the high(at diets supplemented with or without chitosan for five weeks. Twenty-four Sprague-Dawley male rats($235.7{\pm}10.7g$ of body weight) were randomly divided into three groups control group(C) and two treatment groups. Rats in the control group were fed with the high-fat diet containing 10% lard, 1% cholesterol and 0.5% sodium cholate(w/w) which was modified from the formula of the American Institute of Nutrition-76(AIN-76) diet. Rats in treatment groups were red with above diet supplemented with 2.5% of chitosan(CS-2.5) or 5.0% chitosan(CS-5) on the weight to weight basis, respectively. The supplementation of chitosan did not induce any significant difference on the final body weight, gain of body weight and amount of feed intake of rats in between control and treatment groups but the feed efficiency of rats in CS-5 was lower than that of rats in C(p<0.05). The hemoglobin concentrations and hematocrit values showed no significant differences among groups. In addition the values of glucose concentration, total protein, albumin, globulin and albumin/globulin(A/G) ratio showed no significant differences among groups. The values of total cholesterol and low density lipoprotein-cholesterol(LDL-C) in sera of rats in CS-5 were lower than those in both C and CS-2.5(p<0.01). The values of high density lipoprotein-cholesterol (HDL-C) in sera of rats in CS-5 were higher than in both in C and CS-2.5(p<0.05). The values of atherogenic index(AI) of rats in CS-5 were the lowest among groups(p<0.01). AI of CS-2.5 were lower than that or C(p<0.05). The values of triglyceride in sera of rats showed no significant differences among groups. The values of AST in sera of rats in CS-2.5 were lower than those in both C and CS-5(p<0.05). However ALT values showed no significant differences among groups. Therefore the supplementation of chitosan to high fat diet reduced effectively the serum lipid levels such as total cholesterol, LDL-C and triglycerides which were regarded as to cause the cardiovascular diseases moreover it elevated effectively HDL-C value which was regarded protect cardiovascular diseases.

• Archives of Pharmacal Research
• /
• 제25권2호
• /
• pp.178-183
• /
• 2002

A high molecular ar weight water-soluble chitosan (WSC) with an average molecular weight of 300 kD and a deacethylation level of over 90% was produced using a simple multi-step-membrane separation process. It is known that WSC prevents obesity induced by a high-fat diet. Consequently, this study investigated whether or not WSC improved the ovarian dysfunction caused by obesity in mice. The mice were fed a high density protein and lipid diet for weeks, followed by the administration of WSC at 480 mg/kg body weight per day for 4 days. Thereafter, the changes in body weight, ovulation rate, in vivo and in vitro fertilization and emboryonic development were measured . WSC markedly reduced the body weight of obese mice fed with a high-fat diet, but not in mice fed with a normal diet. WSC had siginificant effects on the ovulation rate, both the in vivo and in vitro fertilization rates and embryonic development. These results indicate an improvement in the ovarian and oviduct dysfunction caused by obesity, and suggest an adjustment in the internal secretions and metabolic functions.